Tandem Diabetes (TNDM) director adds shares through RSU grant and vesting
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Tandem Diabetes Care director Rajwant Sodhi reported equity compensation activity. He received a grant of 10,220 restricted stock units (RSUs) on May 20, 2026, which will vest on the one-year anniversary of that date under the company’s 2023 Long-Term Incentive Plan.
Separately, 8,759 previously granted RSUs vested and converted into common shares, increasing his direct common stock holdings to 24,280 shares. These transactions reflect stock-based compensation and derivative exercises rather than open-market buying or selling.
Positive
- None.
Negative
- None.
Insider Trade Summary
8,759 shares exercised/converted
Mixed
3 txns
Insider
Sodhi Rajwant
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Unit | 8,759 | $0.00 | -- |
| Exercise | Common Stock | 8,759 | $0.00 | -- |
| Grant/Award | Restricted Stock Unit | 10,220 | $0.00 | -- |
Holdings After Transaction:
Restricted Stock Unit — 0 shares (Direct, null);
Common Stock — 24,280 shares (Direct, null)
Footnotes (1)
- Each restricted stock units (RSU) represents a contingent right to receive either one share of the Issuers common stock or cash in lieu thereof, at the Issuers discretion, in accordance with the terms of the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan). Such RSUs were granted to the Reporting Person on May 20, 2026, and will vest on the one-year anniversary thereof, subject to the terms of the 2023 Plan. On May 21, 2025, the Reporting Person was granted 8,759 RSUs, all of which vested and converted into shares of the Issuers common stock on the one-year anniversary thereof in accordance with the 2023 Plan.
Key Figures
New RSU grant: 10,220 units
Vested RSUs converted: 8,759 units
Shares held after transactions: 24,280 shares
+2 more
5 metrics
New RSU grant
10,220 units
Restricted stock units granted on May 20, 2026
Vested RSUs converted
8,759 units
Previously granted RSUs that vested and converted to common stock
Shares held after transactions
24,280 shares
Direct common stock holdings following reported Form 4 transactions
Exercise transactions
1 exercise, 8,759 shares
Derivative exercise/conversion activity summarized in transaction data
RSU grant price
$0.00 per unit
Equity compensation award with no cash exercise price
Key Terms
Restricted Stock Unit, 2023 Long-Term Incentive Plan, derivative security, vesting
4 terms
Restricted Stock Unit financial
"The security title includes "Restricted Stock Unit" for two derivative transactions."
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
2023 Long-Term Incentive Plan financial
"RSUs are granted under the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan."
derivative security financial
"The transaction code description notes an "Exercise or conversion of derivative security"."
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
vesting financial
"RSUs "will vest on the one-year anniversary" of the grant date, per the footnote."
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
FAQ
What insider transactions did Tandem Diabetes Care (TNDM) director Rajwant Sodhi report?
Rajwant Sodhi reported equity compensation-related acquisitions. He received 10,220 restricted stock units (RSUs) and saw 8,759 previously granted RSUs vest and convert into common stock, increasing his direct holdings to 24,280 shares. No open-market purchases or sales were reported.
What RSU grant did Tandem Diabetes Care (TNDM) award to Rajwant Sodhi on May 20, 2026?
On May 20, 2026, Tandem Diabetes Care granted Rajwant Sodhi 10,220 restricted stock units. According to the disclosure, these RSUs will vest on the one-year anniversary of the grant date under the company’s 2023 Long-Term Incentive Plan, subject to applicable plan terms.
What happened to the 8,759 restricted stock units previously granted to Rajwant Sodhi at Tandem Diabetes Care?
The 8,759 previously granted restricted stock units fully vested and converted into shares of Tandem Diabetes Care common stock. This conversion increased Rajwant Sodhi’s direct ownership position, contributing to his total of 24,280 common shares reported following the transactions.
Do the reported Tandem Diabetes Care Form 4 transactions involve open-market stock purchases or sales?
The reported transactions do not involve open-market purchases or sales. They reflect a grant of 10,220 restricted stock units and the vesting and conversion of 8,759 previously granted RSUs into common shares, all under the company’s long-term incentive compensation plan.